# INOVIO PHARMACEUTICALS INC – FDA 483, Aug 5, 2026

Source: https://www.keypedia.com/records/483/inovio-pharmaceuticals-inc/8ac61701-031e-4cb9-b8d1-4b3cbd5f5780

> FDA 483 for INOVIO PHARMACEUTICALS INC on August 05, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: INOVIO PHARMACEUTICALS INC
- Inspection Date: 2026-08-05
- Product Type: biologics
- Office Name: Los Angeles District Office
- Summary: An FDA inspection of Inovio Pharmaceuticals, Inc. in San Diego, CA, a control testing laboratory, identified one observation. The firm failed to maintain adequate segregation and control of laboratory materials, including GMP samples, which could lead to errors and contamination. This indicates a moderate severity issue related to laboratory material management.

## Related Officers

- [Lori E. Noffsinger](https://www.keypedia.com/people/lori-e-noffsinger/01ec1ad3-930d-40e4-8323-bf01dd00f77f)
- [Viviana R. Ramirez](https://www.keypedia.com/people/viviana-r-ramirez/1d34f713-edc8-4776-ad70-28fcd59345de)

Company: https://www.keypedia.com/companies/inovio-pharmaceuticals-inc/8b276e6e-d6be-4a71-820a-d01c86ce5245

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b